76652 Federal Register / Vol. 65, No. 236 / Thursday, December 7, 2000 / Notices

tuberoinfundibular peptides of 39

residues (TIP39), also described in this

invention, which binds to a related

receptor. Deletion of amino acids from

the N-terminus of TIP39 resulted in the

high affinity PTH1 receptor antagonist

peptide described here. This peptide

may be used therapeutically to treat

excessive blood calcium caused by PTH

or PTHrP, other pathology caused by

PTHrP, to demonstrate the utility of

parathyroid hormone receptor

antagonism in the treatment of

hypercalcemia or other conditions, or to

help screen for other antagonists at the

parathyroid hormone receptor.

Dated: November 29, 2000.

Jack Spiegel,

Director, Division of Technology Development

and Transfer, Office of Technology Transfer,

National Institutes of Health.

[FR Doc. 00–31216 Filed 12–6–00; 8:45 am]

BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Center for Complementary &

Alternative Medicine; Notice of Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Center for

Complementary and Alternative Medicine

Special Emphasis Panel NCCAM AIDS SEP–

H08.

Date: December 12, 2000.

Time: 12:00 p.m. to 2:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Democracy II, Ste. 106, Bethesda,

MD 20892, (Telephone Conference Call).

Contact Person: Cecelia Maryland, Grants

Technical Assistant, National Center for

Complementary and Alternative Medicine,

National Institutes of Health, Building 31,

Room 5B50, Bethesda, MD 20892, (301) 480–

2419.

Dated: November 30, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–31206 Filed 12–6–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Heart, Lung,

and Blood Institute Special Emphasis Panel,

SCOR-Impact of Injury on the Immature

Pulmonary Circulation.

Date: January 10, 2001.

Time: 8:30 am to 5 pm.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn—Chevy Chase,

Palladian East and Center Rooms, 5520

Wisconsin Avenue, Chevy Chase, MD 20815.

Contact Person: Deborah P. Beebe, PhD,

Chief, Rockledge Center II, 6701 Rockledge

Drive, Suite 7178, Bethesda, MD 20892–7924,

301/435/0270.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.233, National Center for

Sleep Disorders Research; 93.837, Heart and

Vascular Diseases Research; 93.838, Lung

Diseases Research; 93.839, Blood Diseases

and Resources Research, National Institutes

of Health, HHS)

Dated: November 28, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–31199 Filed 12–6–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 522b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Heart, Lung,

and Blood Institute Special Emphasis Panel.

Date: January 7–9, 2001.

Time: 7 pm to 6 pm.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn—Chevy Chase,

Palladian East and Center Rooms, 5520

Wisconsin Avenue, Chevy Chase, MD 20815.

Contact Person: Anne P Clark, PhD, NIH,

NHLBI, DEA, Review Branch, Rockledge II,

6701 Rockledge Drive, Room 7202, Bethesda,

MD 20892–7924, 301/435–0310.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.233, National Center for

Sleep Disorders Research; 93.837, Heart and

Vascular Diseases Research; 93.838, Lung

Diseases Research; 93.839, Blood Diseases

and Resources Research, National Institutes

of Health, HHS)

Dated: November 28, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–31200 Filed 12–6–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Diabetes and

Digestive and Kidney Diseases; Notice

of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections